Satoshi Fujii

5.9k citations
149 papers · 4.5k indexed · 1 hit paper · h-index 35

Satoshi Fujii

146 papers receiving 4.4k citations

Hit Papers

Massive Cell Death of Immature Hematopoietic Cells and Ne...9691995202620052015250500750

Peers

Satoshi Fujii
Comparison fields: 5 of 135
  • Cancer Research 797
  • Hematology 417
  • Immunology 673
  • Internal Medicine 117
  • Cell Biology 459
Replace Hui Liao with:
Hui Liao China
Mariano Sánchez Crespo Spain
Janice Russell United States
Yoshitake Hayashi Japan
Grzegorz Sawicki Canada
Jan Philippé Belgium
Antonio Domenico Procopio Italy
Caroline Wheeler‐Jones United Kingdom
T. Kooistra Netherlands
Dirk Reinhold Germany
Satoshi Fujii relative to Hui Liao China Hui Liao's profile →
Citations per field
00.5×2.6×
Hui Liao · 1×
Citations per year

Countries citing papers authored by Satoshi Fujii

Since Specialization
Citations

This map shows the geographic impact of Satoshi Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Fujii more than expected).

Fields of papers citing papers by Satoshi Fujii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Fujii. The network helps show where Satoshi Fujii may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Satoshi Fujii, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Satoshi Fujii Line = papers co-authored together Satoshi Fujii links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20233
2 202237
3 202278
4 202124
5 20214
6 202117
7 20214
8 202020
9 20203
10 20183
11 201816
12 201613
13 20168
14 201416
15 201290
16 20004
17 20001
18 20001
19
Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Micebreakdown →
1995969
20 19862

About Satoshi Fujii

Satoshi Fujii is a scholar working on Cancer Research, Hematology and Cardiology and Cardiovascular Medicine, having authored 149 papers that have together received 4.5k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (31 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Atherosclerosis and Cardiovascular Diseases (9 papers), Blood properties and coagulation (6 papers) and Cell Adhesion Molecules Research (6 papers). The work is most often cited by research in Cancer Research (797 citations), Hematology (417 citations) and Immunology (673 citations). Satoshi Fujii has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Burton E. Sobel, Hirofumi Sawa, Kei-ichi Nakayama, Noboru Motoyama, Keiko Nakayama, Dennis Y. Loh, Kevin A. Roth, Izumi Negishi, Fanping Wang and Qing Zhang.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026